Unlock instant, AI-driven research and patent intelligence for your innovation.

Fc fusion protein and application thereof

A technology of fusion protein and antigen, applied in Fc fusion protein and its application field, can solve the problem of lack of fusion protein, etc., and achieve the effect of improving curative effect

Active Publication Date: 2020-05-05
武汉九州钰民医药科技有限公司
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The technical problem to be solved by the present invention is to provide an Fc fusion protein and its application in view of the lack of a fusion protein capable of simultaneously blocking the activity of IgE and IL-5 in the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fc fusion protein and application thereof
  • Fc fusion protein and application thereof
  • Fc fusion protein and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Example 1 Synthetic DNA

[0033] The deoxyribonucleic acid fragment FcεRIα (see SEQ ID NO.3 in the sequence listing for details, can also be found in GenBank: E07699.1; the corresponding protein sequence is shown in SEQ ID NO.1 in the sequence listing for details, and can also be found in NCBI ReferenceSequence: NP_001992.1) and hIL5Rα (see SEQ ID NO.4 for details, also found in NCBI ReferenceSequence: NM_000564.4; for the corresponding protein sequence, see SEQ ID NO.2 for details, also found in ACCESSION NP_000555) and human IgG1 Hinge (hinge) connection as arms of Fc (CH2 and CH3 of human IgG1). The name of the recombinantly expressed protein after ligation is FcepsilonRIalph-hIL5Rα-Fc.

[0034] The synthesized DNA was amplified by PCR (primers had enzyme cutting sites), purified, digested, and purified again, and the digested fragments were combined with the expression vector PGKpuro-EF (purchased from Biofeng, http: / / www.biofeng .com / ) to connect. The expression...

Embodiment 2

[0035] Embodiment 2 fusion protein expression

[0036] Using Fugene, 5 μg of the expression plasmid prepared in Example 1 was transformed into 5×10 5CHO cells (purchased from ATCC). After 24 hours, select with 5 μg / ml puromycin (puromycin) (the operation is routine in the field, specifically, replace the cell culture medium containing 5 μg / ml puromycin every 2 to 3 days) until colonies are obviously formed. About 8-10 clones were picked and further amplified. When the number of cells reaches approximately 1 x 10 6 , use 5×10 5 Cells were cultured in 10 ml of antibiotic-free culture medium. After 24 hours, the culture medium was collected to check the production of related proteins. Select 2 to 3 high-expressing clones, continue to select for 1 month in culture medium containing puromycin, select for 1 month without puromycin, and finally select the highest-expressing clone as a stable cell line.

[0037] For the cell culture solution expressing Fc fusion protein, the prot...

Embodiment 3F

[0038] The performance measurement of embodiment 3Fc fusion protein

[0039] 1. Detect the content and activity of FcεRIα or hIL-5Rα in the Fc fusion protein by ELISA. For the detection of FcεRIα, Human FcERI / FcERI ELISA Kit (SandwichELISA) from Lifespan BioSciences, Inc. was used. The operation steps are carried out according to the requirements of its kit. For the detection of hIL5Rα, Interleukin 5 ReceptorΑ, ELISA Kit (#MBS073569) from Mybiosource.com was used. The operation steps are carried out according to the requirements of its kit.

[0040] Test results such as figure 2 As shown in Table 1, it can be seen that after the stable cell line culture fluid is purified by Protein A column, the fusion protein components contained in it are detected by ELISA, and contain the activities of FcεRIα and hIL5Rα. It shows that each protein component of the fusion protein produced by the cell line retains the structure and function of the original protein.

[0041] Table 1 The ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an Fc fusion protein and application thereof. The Fc fusion protein comprises a first antigen binding functional zone, a second antigen binding functional zone, a first Fc chain and a second Fc chain, wherein the first Fc chain and the second Fc chain are connected; the first antigen binding functional zone comprises Fc [epsilon] RI [alpha]; and the second antigen binding functional zone comprises hIL5R [alpha]. Two full human source natural receptors capable of effectively binding IgE with IL-5 can be fused into one molecule, the function and the binding capacity of anoriginal independent receptor are kept, and an in vitro biological function of the Fc fusion protein is almost consistent with the valence of a single receptor or a single antibody. Therefore, on thebasis of a situation that toxic and side effects are not clinically increased, the functions of resisting IgE and IL-5 are combined to achieve an effect on improving a curative effect.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to an Fc fusion protein and its application. Background technique [0002] At present, for moderate to severe asthma diseases, the only biological drug therapy is the use of monoclonal antibodies against IgE or anti-IL-5. Its main function is to block a series of reactions induced by allergic factors and achieve the effect of improving symptoms. However, the pathogenesis of moderate-to-severe asthma is complicated. Blocking the effect of IgE or IL-5 alone can only partially alleviate the patient's symptoms, and if the two drugs are used at the same time, the treatment cost will be greatly increased, and there may be a result that exceeds the tolerance of the human body. Limited toxic side effects. At present, there is no treatment that can block both IgE and IL-5 in the field of medicine. [0003] Although according to relevant experimental reports, water-soluble IgE recept...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C12N15/62C12N15/85C12N5/10A61K38/17A61P11/06A61P37/08
CPCC07K14/7155C12N15/85A61P11/06A61P37/08C07K2317/52A61K38/00
Inventor 黄祥泉胡仁军许勇
Owner 武汉九州钰民医药科技有限公司